FDA Aprroved Sovaldi (sofosbuvir) To Treat Chronic HCV Infection

The first drug, Sovaldi (sofosbuvir) that has optimized safety and efficacy against chronic HCV infection without the concomitant administration of interferons has been granted FDA approval.

Continue reading FDA Aprroved Sovaldi (sofosbuvir) To Treat Chronic HCV Infection